https://orcid.org/0000-0002-7460-4742
References
- ACOG. Practice Bulletin No. 163. Screening for fetal aneuploidy. Obstet Gynecol. 2016;127(5):e123–e137.
- Gil MM, Akolekar R, Quezada MS, et al. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther. 2014;35(3):156–173.
- Livergood MC, LeChien KA, Trudell AS. Obesity and cell-free DNA “no calls”: is there an optimal gestational age at time of sampling?. Am J Obstet Gynecol. 2017;216(4):413.e1–413.e9.
- Krishna I, Badell M, Loucks TL, et al. Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing. Prenat Diagn. 2016;36(3):210–215.
- Gil MM, Quezada MS, Revello R, et al. Analysis of cell-free DNA in maternal blood in screening for fetal aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol. 2015;45(3):249–266.
- Yaron Y. The implications of non-invasive prenatal testing failures: a review of an under-discussed phenomenon. Prenat Diagn. 2016;36(5):391–396.
- Revello R, Sarno L, Ispas A, et al. Screening for trisomies by cell-free DNA testing of maternal blood: consequences of a failed result. Ultrasound Obstet Gynecol. 2016;47(6):698–704.
- Ashoor G, Syngelaki A, Poon LC, et al. Fetal fraction in maternal plasma cell-free DNA at 11–13 weeks’ gestation: relation to maternal and fetal characteristics. Ultrasound Obstet Gynecol. 2013;41(1):26–32.
- Gerovassili A, Nicolaides KH, Thein SL, et al. Cell-free DNA levels in pregnancies at risk of sickle-cell disease and significant ethnic variation. Br J Haematol. 2006;135(5):738–741.
- Haghiac M, Vora NL, Basu S, et al. Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women. Obesity. 2012;20(11):2213–2219.
- Vasavda N, Ulug P, Kondaveeti S, et al. Circulating DNA: a potential marker of sickle cell crisis. Br J Haematol. 2007;139(2):331–336.
- Al-Humood S, Zueriq R, Al-Faris L, et al. Circulating cell-free DNA in sickle cell disease: is it a potentially useful biomarker?. Arch Pathol Lab Med. 2014;138(5):678–683.
- Voskou S, Aslan M, Fanis P, et al. Oxidative stress in beta-thalassaemia and sickle cell disease. Redox Biol. 2015;6:226–239.
- Wang E, Batey A, Struble C, et al. Gestational age and maternal weight effects on fetal cell-free DNA in maternal plasma. Prenat Diagn. 2013;33(7):662–666.
- Shih AW, Bhagirath VC, Heddle NM, et al. Quantification of cell-free DNA in red blood cell units in different whole blood processing methods. J Blood Transfus. 2016;2016:9316385.
- Dar P, Curnow KJ, Gross SJ, et al. Clinical experience and follow-up with large scale single-nucleotide polymorphism-based noninvasive prenatal aneuploidy testing. Am J Obstet Gynecol. 2014;211(5):527.e1–527.e17.
- Rolnik DL, da Silva Costa F, Lee TJ, et al. Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia. Ultrasound Obstet Gynecol. 2018;52(6):722–727.
- Wright D, Wright A, Nicolaides KH. A unified approach to risk assessment for fetal aneuploidies. Ultrasound Obstet Gynecol. 2015;45(1):48–54.
- Artieri CG, Haverty C, Evans EA, et al. Noninvasive prenatal screening at low fetal fraction: comparing whole-genome sequencing and single-nucleotide polymorphism methods. Prenat Diagn. 2017;37(5):482–490.